VF
ENVB icon

Virtu Financial’s Enveric Biosciences ENVB Stock Holding History

Virtu Financial’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
+10,690
New +$25.7K ﹤0.01% 1385
2025
Q3 		– Sell
-1,730
Closed -$25K – 1631
2025
Q2 		$25K Sell
1,730
-405
-19% -$6.14K ﹤0.01% 1232
2025
Q1 		$36K Buy
2,135
+1,825
+589% +$63.2K ﹤0.01% 1048
2024
Q4 		$20K Buy
310
+182
+142% +$13.2K ﹤0.01% 1299
2024
Q3 		$11K Buy
128
+51
+66% +$4.69K ﹤0.01% 1192
2024
Q2 		$9K Sell
77
-111
-59% -$16.7K ﹤0.01% 1138
2024
Q1 		$34K Buy
+188
New +$36.2K ﹤0.01% 1082
2023
Q2 		– Sell
-59
Closed -$18K – 1655
2023
Q1 		$18K Buy
+59
New +$24.8K ﹤0.01% 1261
2022
Q3 		– Sell
-19
Closed -$36K – 1858
2022
Q2 		$36K Sell
19
-12
-39% -$25.5K ﹤0.01% 1205
2022
Q1 		$91K Buy
31
+15
+94% +$66.3K 0.01% 996
2021
Q4 		$131K Buy
16
+10
+167% +$141K 0.01% 1006
2021
Q3 		$113K Hold
6
– – 0.01% 1102
2021
Q2 		$126K Sell
6
-14
-70% -$300K 0.01% 1140
2021
Q1 		$556K Buy
20
+19
+1,900% +$664K 0.04% 468
2020
Q4 		$45K Buy
+1
New +$52.5K ﹤0.01% 1245
2020
Q3 		– Sell
-1
Closed -$70K – 1191
2020
Q2 		$70K Buy
+1
New +$47.3K 0.01% 952
2018
Q2 		– Hold
0
– -$23K – 2098
2018
Q1 		– Hold
0
– – – 1807

Other funds holding ENVB

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

Virtu Financial's ENVB Position: Q2 2026 in Review

Virtu Financial opened a new position in Enveric Biosciences (ENVB) in Q2 2026: 10,690 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #1385 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ENVB as recently as Q2 2025.

Virtu Financial first reported a position in ENVB in Q2 2020 and has held it in 16 quarters since. The position peaked at $556K in Q1 2021. 15 funds tracked by Wall St. Rank hold ENVB as of Q2 2026.

  • Virtu Financial held 10,690 shares of Enveric Biosciences worth $15K as of Q2 2026.
  • Enveric Biosciences was a new Virtu Financial position in Q2 2026.
  • Enveric Biosciences made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1385 holding.
  • Virtu Financial first reported a position in Enveric Biosciences in Q2 2020 and has held it in 16 quarters since.
  • Virtu Financial's Enveric Biosciences position peaked at $556K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.